Differing Phospholipase A2 Receptor (PLA2R) Antibody Decline Kinetics After Obinutuzumab in High-Risk Membranous Nephropathy: Report of Two Cases
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.2026e6pr3cbm ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Shi Yun Tan und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tan, S. Y., Jun, J. C. C., Loo, K. P., Wong, J., & Tan, H. Z. (2026). Differing Phospholipase A2 Receptor (PLA2R) Antibody Decline Kinetics After Obinutuzumab in High-Risk Membranous Nephropathy: Report of Two Cases. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026e6pr3cbm
Vancouver
Tan SY, Jun JCC, Loo KP, Wong J, Tan HZ. Differing Phospholipase A2 Receptor (PLA2R) Antibody Decline Kinetics After Obinutuzumab in High-Risk Membranous Nephropathy: Report of Two Cases. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026e6pr3cbm
BibTeX
@article{Tan2026,
author = {Tan, Shi Yun and Jun, Jason Choo Chon and Loo, Kok pan and Wong, Jiunn and Tan, Hui Zhuan},
title = {Differing Phospholipase A2 Receptor (PLA2R) Antibody Decline Kinetics After Obinutuzumab in High-Risk Membranous Nephropathy: Report of Two Cases},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.2026e6pr3cbm}
}
EUVIMED